Siegfried names Eduardo Montanha COO, effective Sept. 1

• Siegfried appointed Eduardo Montanha as chief operating officer, joining the executive committee from Sept. 1, 2026.
• The move merges COO responsibilities for drug substances and drug products into a single role.
• The company aims to strengthen end-to-end CDMO offerings across the pharmaceutical value chain, from drug substances to drug products.
• Montanha was EVP, head of global technical operations and quality at Fresenius Kabi, overseeing about 30 manufacturing sites worldwide.
• He previously held senior roles in manufacturing, quality, and supply at Takeda, Sandoz, Hexal, Hoechst/Aventis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Siegfried Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2366246_en) on July 16, 2026, and is solely responsible for the information contained therein.